Hum. Reprod. Advance Access originally published online on February 26, 2007
Human Reproduction 2007 22(6):1626-1633; doi:10.1093/humrep/dem027
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury
1 Department of Obstetrics and Gynecology 2 Department of Oncology 3 Department of Pathology, Sheba Medical Center, Israel
4 To whom correspondence should be addressed at: IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, 52621 Tel-Hashomer, Israel. Tel.: +972-3-5302882; Fax: +972 3 5341589; E-mail: meirow{at}post.tau.ac.il
BACKGROUND: Chemotherapy destroys primordial follicles and can lead to ovarian atrophy. Although reports indicate that apoptosis is the mechanism responsible for follicle loss, additional pathways can be involved. This study investigates the damage in human ovaries after administration of non-sterilizing doses of chemotherapy.
METHODS: In a blind study, pathological changes in ovarian tissue harvested for cryopreservation were evaluated. The study group comprised young non-sterile cancer patients, previously exposed to chemotherapy who were (mean ± SD), when compared with non-exposed patients.
RESULTS: Thirty-five cancer patients aged 28.7 ± 6.74; 17 were previously exposed to non-sterilizing chemotherapy and 18 were not. In all samples, primordial follicles were present. In previously exposed patients, damage to cortical blood vessel and proliferation of small vessels was observed. The cortex showed focal areas of fibrosis with disappearance of follicles (sensitivity 76%, positive predictive value 75% for <37 years old patients). Older patients, not exposed to chemotherapy (5/7) showed similar pathological changes.
CONCLUSIONS: Injury to blood vessels and focal ovarian cortical fibrosis are aspects of ovarian damage caused by chemotherapy. These findings indicate a potential additional mechanism of damage to the direct apoptotic effect of chemotherapy on follicles. The possibility that these changes are involved in ageing ovaries should be further investigated.
Key words: blood vessels/chemotherapy/fibrosis/ovary/primordial follicles
Submitted on November 23, 2006; accepted on December 8, 2006.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Demeestere, P. Simon, S. Emiliani, A. Delbaere, and Y. Englert Orthotopic and heterotopic ovarian tissue transplantation Hum. Reprod. Update, November 1, 2009; 15(6): 649 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-M. Dolmans, J. Donnez, A. Camboni, D. Demylle, C. Amorim, A. Van Langendonckt, and C. Pirard IVF outcome in patients with orthotopically transplanted ovarian tissue Hum. Reprod., November 1, 2009; 24(11): 2778 - 2787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Delgado-Rosas, M. Gaytan, C. Morales, R. Gomez, and F. Gaytan Superficial ovarian cortex vascularization is inversely related to the follicle reserve in normal cycling ovaries and is increased in polycystic ovary syndrome Hum. Reprod., May 1, 2009; 24(5): 1142 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Maman, K. Prokopis, J. Levron, A. Carmely, J. Dor, and D. Meirow Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study Hum. Reprod., January 1, 2009; 24(1): 206 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Beck-Fruchter, A. Weiss, and E. Shalev GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data Hum. Reprod. Update, November 1, 2008; 14(6): 553 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Elizur, R. C. Chian, C. A. Pineau, W. Y. Son, H. E. G. Holzer, J. Y. J. Huang, Y. Gidoni, D. Levin, E. Demirtas, and S. L. Tan Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents Rheumatology, October 1, 2008; 47(10): 1506 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Abir, A. Ben-Haroush, C. Felz, E. Okon, H. Raanani, R. Orvieto, S. Nitke, and B. Fisch Selection of patients before and after anticancer treatment for ovarian cryopreservation Hum. Reprod., April 1, 2008; 23(4): 869 - 877. [Abstract] [Full Text] [PDF]
|
|